Crescita Therapeutics™ Announces Agreement with Taro Pharmaceuticals for Pliaglis® PR Newswire MISSISSAUGA, ON, April 25, 2017 MISSISSAUGA, ON , April 25, 2017 /PRNewswire/ - Crescita Therapeutics Inc. (TSX:CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drugs, today announced it has entered into a development and commercialization license agreement (the Agreement) with Taro Pharmaceuticals Inc. (Taro),...